Search details
1.
Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes.
Int J Mol Sci
; 24(3)2023 Jan 26.
Article
in English
| MEDLINE | ID: mdl-36768754
2.
Alectinib rescue therapy in advanced ALK rearranged lung adenocarcinoma: a case report.
Monaldi Arch Chest Dis
; 93(3)2022 Sep 20.
Article
in English
| MEDLINE | ID: mdl-36128929
3.
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50.
Cancer Immunol Immunother
; 69(11): 2209-2221, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32474768
4.
Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC.
Int J Mol Sci
; 21(14)2020 Jul 12.
Article
in English
| MEDLINE | ID: mdl-32664698
5.
Prognostic Factors and Biomarkers of Responses to Immune Checkpoint Inhibitors in Lung Cancer.
Int J Mol Sci
; 20(19)2019 Oct 05.
Article
in English
| MEDLINE | ID: mdl-31590386
6.
Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients.
Int J Mol Sci
; 20(9)2019 May 07.
Article
in English
| MEDLINE | ID: mdl-31067796
7.
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
Br J Cancer
; 116(6): 802-810, 2017 Mar 14.
Article
in English
| MEDLINE | ID: mdl-28170370
8.
The Treatment of a New Entity in Advanced Non-Small Cell Lung Cancer: MET exon 14 Skipping Mutation.
Curr Med Chem
; 2023 Aug 03.
Article
in English
| MEDLINE | ID: mdl-37534484
9.
Recently approved and emerging monoclonal antibody immune checkpoint inhibitors for the treatment of advanced non-small cell lung cancer.
Expert Opin Biol Ther
; 23(3): 261-268, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36803090
10.
Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Cancers (Basel)
; 15(19)2023 Sep 22.
Article
in English
| MEDLINE | ID: mdl-37835378
11.
First-line treatment of advanced non-small cell lung cancer with ALK rearrangement: state of the art and future development.
Expert Rev Respir Med
; 16(3): 315-321, 2022 03.
Article
in English
| MEDLINE | ID: mdl-30920858
12.
The role of antiangiogenic monoclonal antibodies combined to EGFR-TKIs in the treatment of advanced non-small cell lung cancer with activating EGFR mutations: acquired resistance mechanisms and strategies to overcome them.
Cancer Drug Resist
; 5(4): 1016-1024, 2022.
Article
in English
| MEDLINE | ID: mdl-36627900
13.
Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going?
Expert Rev Anticancer Ther
; 22(2): 183-189, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34989305
14.
Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review.
Cancers (Basel)
; 14(23)2022 Nov 25.
Article
in English
| MEDLINE | ID: mdl-36497292
15.
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients.
Crit Rev Oncol Hematol
; 169: 103536, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34801697
16.
RNA-based next-generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center.
Per Med
; 19(5): 395-401, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35801400
17.
The treatment of advanced lung adenocarcinoma with activating EGFR mutations.
Expert Opin Pharmacother
; 22(18): 2475-2482, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34281457
18.
The role of nivolumab combined to immunotherapy and/or chemotherapy in the first-line treatment of advanced Non Small Cell Lung Cancer.
Expert Opin Biol Ther
; 21(3): 303-309, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33355496
19.
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment.
Expert Rev Respir Med
; 15(11): 1415-1425, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34374626
20.
Tumor mutational burden on cytological samples: A pilot study.
Cancer Cytopathol
; 129(6): 460-467, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33378102